Dolby Laboratories (NYSE:DLB) SVP Sells $188,130.00 in Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $62.71, for a total transaction of $188,130.00. Following the transaction, the senior vice president directly owned 73,274 shares of the company’s stock, valued at $4,595,012.54. The trade was a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Dolby Laboratories Stock Up 2.4%

Shares of DLB stock opened at $64.21 on Friday. The stock has a market cap of $6.01 billion, a P/E ratio of 27.32 and a beta of 0.80. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $75.66. The company’s fifty day simple moving average is $54.23 and its two-hundred day simple moving average is $58.45.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. During the same quarter in the prior year, the firm earned $0.78 EPS. The business’s revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, analysts anticipate that Dolby Laboratories will post 3.26 EPS for the current fiscal year.

Dolby Laboratories announced that its board has initiated a share buyback program on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to buy up to 7% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.2%. The ex-dividend date was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.

Analyst Upgrades and Downgrades

DLB has been the topic of several recent research reports. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings downgraded shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 13th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, July 31st. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $83.00.

Institutional Investors Weigh In On Dolby Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DLB. Boothbay Fund Management LLC boosted its stake in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after purchasing an additional 157 shares during the period. Covestor Ltd increased its stake in Dolby Laboratories by 6.0% in the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after buying an additional 175 shares during the period. Fifth Third Bancorp increased its stake in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after buying an additional 192 shares during the period. State of Michigan Retirement System lifted its holdings in Dolby Laboratories by 1.4% during the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock valued at $883,000 after buying an additional 200 shares in the last quarter. Finally, Raymond James Financial Inc. lifted its holdings in Dolby Laboratories by 1.0% during the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after buying an additional 235 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.